Reynold A. Panettieri, Jr, M.D.

Reynold A. Panettieri, Jr, M.D.

Vice Chancellor for Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science Professor of Medicine, Robert Wood Johnson Medical School Emeritus Professor of Medicine, University of Pennsylvania

Molecular Nanomechanical Mapping of Histamine-Induced Smooth Muscle Cell Contraction and ShorteningMolecular Nanomechanical Mapping of Histamine-Induced Smooth Muscle Cell Contraction and Shortening.

Rutgers Institute for Translational Medicine and Science
Child Health Institute of New Jersey
Rutgers, The State University of New Jersey
89 French Street
New Brunswick, NJ 08901

(732) 235-6404



M.D., University of Pennsylvania, Philadelphia, PA


Hospital of the University of Pennsylvania, Philadelphia, PA


Hospital of the University of Pennsylvania, Philadelphia, PA
Reynold A. Panettieri, Jr, MD, the inaugural Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University, previously served as the Director of the Airways Biology Initiative at the University of Pennsylvania. His interests include the cellular and molecular mechanisms that regulate airway smooth muscle cell growth and the immunobiology of airway smooth muscle. Consequences of increases in airway smooth muscle growth promote the development of irreversible airflow obstruction and airway remodeling seen in patients with chronic severe asthma. Dr. Panettieri’s lab also focuses on cytosolic signaling pathways that mediate gene expression and alter myocyte growth.

Dr. Panettieri also served as the Deputy Director of the Center of Excellence in Environmental Toxicology at the University of Pennsylvania. He directed the human exposure chamber that defines the molecular mechanisms regulating ozone- and particulate matter-induced airway hyperresponsiveness.
In addition to his research and clinical interests, Dr. Panettieri served as chairperson of the NIH Lung Cellular, Molecular, and Immunobiology Study Section, is a member of the NIH Distinguished Editorial Panel, and is a member of the American Society for Clinical Investigation and Association of American Physicians.

Current basic research projects open to fellow participation:

  • Immunobiology of airway smooth muscle: A major emphasis of our laboratory focuses on the immunobiology of airway smooth muscle (ASM) cells in asthma and chronic obstructive pulmonary disease (COPD). We have characterized that ASM can orchestrate and perpetuate airway inflammation through the secretion of chemokines/cytokines and expression of cell adhesion molecules. We define the critical signaling pathways by which structural cells modulate inflammatory responses, specifically the interplay of nuclear receptors such as vitamin D and glucocorticoids in inhibiting pro-inflammatory signals in mesenchymal cells.
  • Airway smooth muscle growth and airway remodeling: In some but not all patients with asthma, irreversible airflow obstruction occurs that evokes morbidity and mortality. A seminal finding of airway remodeling is increases in ASM mass. Our studies have recently defined that Regulators of G protein coupled Signaling (RGS) modulate ASM contractile responses and promote ASM cell growth. Our studies focus on novel approaches to inhibit ASM growth and maintain the contractile nature of human ASM cells. Specific tools utilize molecular approaches for cell signaling, as well as, novel imaging of cytosolic calcium and confocal bronchoscopy.
  • Environmental health studies and airway smooth muscle cell function: Ozone and other environmental toxins can induce airway hyperresponsiveness. The molecular mechanisms regulating ozone-mediated airway inflammation and airway hyperresponsiveness remain unclear. Our studies have defined novel eicosanoids and prostaglandins that mediate ozone-induced inflammation. Using translational biologic approaches in which a human exposure chamber delivers ozone to well-characterized patients with asthma and COPD, the characteristics of airway hyperresponsiveness and the molecular mechanisms regulating these phenotypes are defined.
  • Novel therapeutic approaches to treat airways diseases: Our laboratory has devoted considerable effort to collaborate with most major pharmaceutical companies to identify novel targets and platforms to test new therapeutic approaches in asthma and COPD. Using precision cut lung slices (PCLS) from humans and mice, the fundamental processes that regulate ASM contraction and growth can be defined, and novel therapeutics to inhibit such processes are characterized.

Selected publications

  1. Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study. Horton DB, Barrett ES, Roy J, Gennaro ML, Andrews T, Greenberg P, Bruiners N, Datta P, Ukey R, Velusamy SK, Fine D, Honnen WJ, Yin YS, Pinter A, Brooks A, Tischfield J, Hussain S, Jagpal S, Swaminathan S, Parmar V, Reilly N, Gaur S, Panettieri RA Jr, Carson JL, Blaser MJ.  J Infect Dis. 2021 Aug 13:jiab411. doi: 10.1093/infdis/jiab411. Online ahead of print. PMID: 34387310.
  2. Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States. Panettieri RA Jr, Chipps BE, Moore WC, Soong W, Carr WW, Kreindler JL, O’Quinn S, Trudo F, Ambrose CS. J Asthma. 2021 Aug 10:1-13. doi: 10.1080/02770903.2021.1963766. Online ahead of print. PMID: 34374622.
  3. Editorial policy regarding the citation of preprints in the British Journal of Pharmacology (BJP). George CH, Alexander SPH, Cirino G, Insel PA, Izzo AA, Ji Y, Kendall DA, Panettieri RA, Patel HH, Sobey CG, Stanford SC, Stefanska B, Stephens G, Teixeira M, Ahluwalia A. Br J Pharmacol. 2021 Jul 30. doi: 10.1111/bph.15589. Online ahead of print. PMID: 34328225.
  4. Diacylglycerol Kinase Inhibition Reduces Airway Contraction by Negative Feedback Regulation of Gq-signaling.  Sharma P, Yadav SK, Shah SD, Javed E, Lim JM, Pan S, Nayak AP, Panettieri RA Jr., Penn RB, Kambayashi T, Deshpande DA. Am J Respir Cell Mol Biol. 2021 Jul 22. doi: 10.1165/rcmb.2021-0106OC. Online ahead of print. PMID: 34293268.
  5. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection. Datta P, Ukey R, Bruiners N, Honnen W, Carayannopoulos MO, Reichman C, Choudhary A, Onyuka A, Handler D, Guerrini V, Mishra PK, Dewald HK, Lardizabal A, Lederer L, Leiser AL, Hussain S, Jagpal SK, Radbel J, Bhowmick T, Horton DB, Barrett ES, Xie YL, Fitzgerald-Bocarsly P, Weiss SH, Woortman M, Parmar H, Roy J, Dominguez-Bello MG, Blaser MJ, Carson JL, Panettieri RA, Libutti SK, Raymond HF, Pinter A, Gennaro ML. medRxiv. 2021 Jul 14:2021.07.09.21260266. doi: 10.1101/2021.07.09.21260266. Preprint. PMID: 34282427.
  6. Metabolomics in asthma: A platform for discovery.Xu S, Panettieri RA Jr, Jude J. Mol Aspects Med. 2021 Jul 16:100990. doi: 10.1016/j.mam.2021.100990. Online ahead of print. PMID: 34281719.
  7. Autocrine regulation of airwway smooth muscle contraction by diacylglycerol kinase. Yadav SK, Sharma P, Shah SD, Panettieri RA, Kambayashi T, Penn RB, Deshpande DA.J Cell Physiol. 2021 Jul 18. doi: 10.1002/jcp.30528. Online ahead of print. PMID: 34278583.
  8. Exacerbations in US Severe Asthma: Incidence, Characteristics, Predictors, and Effects of Biologic Treatments.Trevor J, Lugogo N, Carr W, Moore WC, Soong W, Panettieri RA Jr, Desai P, Trudo F, Ambrose CS.  Ann Allergy Asthma Immunol. 2021 Jul 14:S1081-1206(21)00501-9. doi: 10.1016/j.anai.2021.07.010. Online ahead of print. PMID: 34273485.
  9. Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines. Jimenez ME, Rivera-Núñez Z, Crabtree BF, Hill D, Pellerano MB, Devance D, Macenat M, Lima D, Martinez Alcaraz E, Ferrante JM, Barrett ES, Blaser MJ, Panettieri RA Jr, Hudson SV. JAMA Netw Open. 2021 Jul 1;4(7):e2117074. doi: 10.1001/jamanetworkopen.2021.17074. PMID: 34264327.
  10. Molecular Nanomechanical Mapping of Histamine-Induced Smooth Muscle Cell Contraction and Shortening. Jo MH, Kim BC, Sung K, Panettieri RA Jr, An SS, Liu J, Ha T. ACS Nano. 2021 Jul 1. doi: 10.1021/acsnano.1c01782. Online ahead of print. PMID: 34197709.
  11. Na+/H+ Exchanger Regulatory Factor 1 Mediates the Pathogenesis of Airway Inflammation in a Murine Model of House Dust Mite-Induced Asthma. Kammala AK, Bahal D, Yang C, Panettieri RA Jr, Das R, Subramanian H. J Immunol. 2021 May 15;206(10):2301-2311. doi: 10.4049/jimmunol.2001199. Epub 2021 May 5. PMID: 33952618.
  12. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21. PMID: 33882225.
  13. Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells. Mishra PK, Bruiners N, Ukey R, Datta P, Onyuka A, Handler D, Hussain S, Honnen W, Singh S, Guerrini V, Yin Y, Dewald H, Choudhary A, Horton DB, Barrett ES, Roy J, Weiss SH, Fitzgerald-Bocarsly P, Blaser MJ, Carson JL, Panettieri RA, Lardizabal A, Chang TL, Pinter A, Gennaro ML.medRxiv. 2021 Apr 14:2021.04.11.21255153. doi: 10.1101/2021.04.11.21255153. Preprint. PMID: 33880486.
  14. Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.Staquicini DI, Barbu EM, Zemans RL, Dray BK, Staquicini FI, Dogra P, Cardó-Vila M, Miranti CK, Baze WB, Villa LL, Kalil J, Sharma G, Prossnitz ER, Wang Z, Cristini V, Sidman RL, Berman AR, Panettieri RA Jr, Tuder RM, Pasqualini R, Arap W.  Med (N Y). 2021 Mar 12;2(3):321-342. doi: 10.1016/j.medj.2020.10.005. Epub 2020 Dec 10. PMID: 33870243.
  15. Functional NMDA receptors are expressed by human pulmonary artery smooth muscle cells. Dong YN, Hsu FC, Koziol-White CJ, Stepanova V, Jude J, Gritsiuta A, Rue R, Mott R, Coulter DA, Panettieri RA Jr, Krymskaya VP, Takano H, Goncharova EA, Goncharov DA, Cines DB, Lynch DR.  Sci Rep. 2021 Apr 15;11(1):8205. doi: 10.1038/s41598-021-87667-0. PMID: 33859248.
  16. RGS proteins, GRKs, and beta-arrestins modulate G protein-mediated signaling pathways in asthma. Fuentes N, McCullough M, Panettieri RA Jr, Druey KM. Pharmacol Ther. 2021 Jul;223:107818. doi: 10.1016/j.pharmthera.2021.107818. Epub 2021 Feb 15. PMID 33600853.
  17. Airway smooth muscle and airway hyperresponsiveness in asthma – mechanisms of airway smooth muscle dysfunction. Gebski EB, Anaspure O, Panettieri RA, Koziol-White CJ. Minerva Med. 2021 Jan 26. doi: 10.23736/S0026-4806.21.07283-9. Online ahead of print. PMID: 33496164.
  18. Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice. Wechsler ME, Peters SP, Hill TD, Ariely R, DePietro MR, Driessen MT, Terasawa EL, Thomason DR, Panettieri RA Jr. Chest. 2021 May;159(5):1734-1746. doi: 10.1016/j.chest.2020.11.060. Epub 2020 Dec 14. PMID: 33333058.
  19. An inherent dysfunction in soluble guanylyl cyclase is present in the airway of severe asthmatics and is associated with aberrant redox enzyme expression and compromised NO-cGMP signaling. Ghosh A, Koziol-White CJ, Jester WF Jr, Erzurum SC, Asosingh K, Panettieri RA Jr, Stuehr DJ. Redox Biol. 2021 Feb;39:101832. doi: 10.1016/j.redox.2020.101832. Epub 2020 Dec 13. PMID: 33360351.
  20. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020. Barrett ES, Horton DB, Roy J, Xia W, Greenberg P, Andrews T, Gennaro ML, Parmar V, Russell WD, Reilly N, Uprety P, Gantner JJ, Stockman L, Trooskin SZ, Blaser MJ, Carson JL, Panettieri RA Jr. Open Forum Infect Dis. 2020 Oct 31;7(12):ofaa534. eCollection 2020 Dec.